Quick Answer
Medical and life-sciences companies should treat EOR as a compliance-risk decision, not a fee bake-off. Prioritize owned-entity clarity, credential and licensing coordination, HIPAA/GDPR data controls, and termination process for regulated roles. Remote is usually the safer default for defensibility; Deel wins when you must hire fast across many markets and roles are mostly non-clinical.
What “medical company” hiring actually looks like
Most international EOR demand in this sector is not for surgeons. It is for:
- Regulatory affairs, quality, and clinical operations staff
- Pharmacovigilance, medical writing, and market access roles
- Software, data, and commercial teams supporting devices or therapies
- Occasional licensed clinicians where local registration allows third-party employment
Patient-facing clinical employment through an EOR is the exception. Many jurisdictions require the employing entity to hold or sponsor professional registration, facility affiliation, or both. If your hiring plan assumes “EOR can employ any MD anywhere,” stop and map licenses by country before vendor demos. Ranked provider picks live on Best EOR for Healthcare Companies.
How medical buyers should evaluate (before features)
| Priority | What to verify | Red flag |
|---|---|---|
| Entity model | Owned vs partner in each target country | “We cover 150+” with no country map |
| Credential workflow | Who checks license status, renewal, and scope of practice | “HR will handle it” with no playbook |
| Data / privacy | DPA, subprocessors, breach SLA, health data handling | No healthcare addendum, vague HIPAA claims |
| Termination | Offboarding for licensed vs non-licensed roles | One global offboarding template |
| Benefits | Market-standard clinical vs corporate packages | Generic brochure benefits only |
| Audit trail | Contract versions, pay registers, policy acknowledgements | PDF invoices with no exportable register |
Use the broader risk framework on EOR compliance risks and score vendors with how to choose an EOR.
Clinical vs non-clinical: different EOR fit
| Role type | EOR fit | Why |
|---|---|---|
| Software, ops, commercial, RA/QA (non-licensed) | Strong | Standard employment contracts and payroll |
| Medical science liaison / medical affairs (often licensed) | Conditional | License must travel with employment model |
| Patient-facing clinician | Often poor | Facility privileges, local employer of record rules |
| Contractor consultants | Risky | Misclassification heat is high in regulated work |
If more than ~30% of planned headcount needs active professional licenses, budget local counsel reviews per country. EOR sales decks will not substitute for that.
Provider posture for medical teams (summary, not a ranked listicle)
Full rankings and score methodology: Best EOR for Healthcare Companies.
| Provider | When medical buyers shortlist | Trade-off | Typical list signal |
|---|---|---|---|
| Remote | Legal-chain quality, IP, owned entities | Narrower coverage (~90+) | EOR ~$699/mo |
| Deel | Fast multi-country hiring, contractor bridge | Partner entities in many markets | EOR ~$599/mo; contractors $49/mo |
| Papaya Global | Hybrid payroll + employment reporting | Heavier implementation | EOR ~$599/mo; payroll custom |
| G-P / enterprise EORs | Complex enterprise procurement | Price and sales-cycle length | Custom |
Default rule of thumb: Non-clinical global expansion with high IP sensitivity → Remote where covered. Speed across 20+ markets with mostly corporate roles → Deel. Already running owned entities and need payroll consolidation → Papaya.
Not for Remote: Broad maps into markets Remote does not cover, or contractor-heavy consulting models. Not for Deel: Buyers who refuse partner entities in any regulated market. Not for bargain EORs: Anyone handling patient data or license-bound roles where a $200/month discount is irrelevant next to audit risk.
Concrete cost scenario: 10-person medical ops team
Assume average EOR fee $599/employee/month (list), three countries (US parent hiring into Germany, UK, and India), blended average gross $7,500/month.
| Line | Monthly | Annual |
|---|---|---|
| Gross wages (10 × $7,500) | $75,000 | $900,000 |
| Employer statutory (blended ~20%) | ~$15,000 | ~$180,000 |
| EOR fees (10 × $599) | $5,990 | $71,880 |
| Supplemental benefits / private medical (assume ~$200/seat) | ~$2,000 | ~$24,000 |
| All-in before FX | ~$97,990 | ~$1.18M |
Cutting the EOR fee to $499 saves ~$12,000/year. A single delayed hire because licensing was not scoped (six weeks of idle salary plus lost trial milestone) routinely costs more than that. Model alternatives in the EOR cost calculator and pricing hub.
Data, privacy, and “HIPAA-compatible” claims
US HIPAA does not magically apply to every foreign employment relationship, but buyers still need:
- A signed DPA with subprocessor transparency
- Clear rules for where employee health data and candidate medical questionnaires live
- Breach notification timelines that match your incident response plan
- Separation between HRIS notes and any clinical systems of record
If a provider markets “HIPAA compliant EOR” without a healthcare data addendum, treat it as marketing. GDPR still applies for EU/UK employment data regardless of your HQ. For SOC 2 / security diligence context, see EOR SOC 2 compliance and EOR data privacy / GDPR.
Termination and credential risk
Medical companies under-budget exits. Two failure modes:
- Licensed employee termination without documenting who notifies the professional board or employer of record of practice status changes.
- Access offboarding that closes HRIS login but leaves clinical or quality system credentials active for days.
Ask for a sample offboarding runbook for a licensed role in your top country. If the answer is the same checklist used for a marketing hire, keep shopping. Country-level exit rules (notice, severance, works councils) still apply; start from country guides such as Germany and UK when those are target markets.
When EOR is the wrong model for medical expansion
- You need hospital privileges or clinic employment that only a local healthcare employer can sponsor
- Headcount in one country will exceed ~15–20 for 18+ months and you already have a legal entity path
- You are converting long-term “consultants” who look like employees under local tests (contractor vs employee, EOR vs contractor)
- Your product requires on-site controlled substance handling tied to a facility license you do not hold
In those cases, use EOR only as a bridge for corporate roles while local counsel scopes clinical employment. Compare entity economics on EOR vs entity.
Country operating notes medical buyers ask about
You do not need a global clinical employment theory. You need friction maps for the three countries in your first hiring wave.
| Market pattern | What breaks EOR plans | Where to read more |
|---|---|---|
| Germany / EU hubs | Works councils on the EOR entity, long notice, high social charges (~20%+ employer) | Germany guide |
| UK | Right-to-work checks, IR35-adjacent contractor risk if you mix models | UK guide |
| US outbound into LatAm / India | Time-zone support for PV and quality tickets; contractor misclassification heat | India guide, contractor vs employee |
For device or pharma companies opening a EU regulatory hub, EOR for RA/QA writers and software staff is common in year one. Facility-tied GMP roles are not. Separate those hiring tracks in the same RFP so vendors cannot blur them.
IP assignment language matters more here than in generic SaaS hiring. Require invention assignment that survives local employee-friendly default rules, and confirm the chain of title when the employing entity is a partner EOR. If the MSA is silent on partner-entity IP flow-down, assume you will renegotiate later under time pressure.
Second cost scenario: converting 4 “consultants” to employees
Assume four medical affairs contractors billed at $10,000/month each ($480,000/year cash), paid via Wise-class rails at 0.5% friction ($2,400/year). Reclassify to EOR employees at $9,000/month gross equivalent:
| Line | Annual |
|---|---|
| Gross (4 × $9,000 × 12) | $432,000 |
| Employer statutory (blended ~20%) | ~$86,400 |
| EOR fees (4 × $599 × 12) | ~$28,752 |
| All-in employment cost | ~$547,000 |
Cash compensation may look lower than contractor invoices, but statutory + EOR fees push total above the old contractor bill. The point of conversion is risk reduction and control, not a guaranteed save. If you keep them as contractors, price the audit and back-tax risk explicitly with counsel. Payment-rail choice alone will not fix classification; see Wise vs Payoneer vs Deel vs Remote.
Procurement checklist (medical-specific)
- Country list with role types (licensed / non-licensed) and salary bands
- Written owned vs partner map for each country
- Credential verification RACI and average calendar days
- Healthcare or sensitive-data addendum + subprocessor list
- Sample contracts with IP, confidentiality, and invention assignment language
- Termination runbook for licensed roles
- All-in year-one quote including deposits, FX, benefits admin, and off-cycle payroll
- Pilot one non-clinical hire before scaling licensed roles
Frequently Asked Questions
Can an EOR hire doctors or nurses internationally?
Sometimes, and only where local law and professional regulators allow the EOR entity to be the employer of a licensed clinician. Many markets effectively require employment through a licensed healthcare organization. Confirm per country before offers; do not rely on a global sales claim.
Is Remote better than Deel for healthcare companies?
For most compliance-first medical buyers, yes where Remote covers the map, because owned-entity posture and documentation quality matter more than onboarding speed. Deel is better when you need breadth and speed for mostly non-clinical roles. Details and ranking: Best EOR for Healthcare Companies.
Do we need different benefits for clinical vs corporate staff?
Often yes. Market practice for clinicians can include higher private medical coverage, indemnity support, or schedule premiums that corporate packages omit. Ask for a benefits matrix by role family and country, not a single global brochure.
How should we handle contractors in medical affairs?
Carefully. Long-term exclusive MSLs or QA specialists paid as contractors create misclassification and data-access risk. Prefer employee/EOR for ongoing controlled work; reserve true project consultants for defined scopes. See contractor vs employee global.
When should a biotech skip EOR and open entities?
When one hub (for example Germany or UK) hits stable 15–20+ employees, you need facility-tied employment, or investors demand direct employment for IP/tax reasons. Until then, EOR for non-clinical roles is usually cheaper and faster than premature entity sprawl.
What contract terms matter most?
IP assignment, confidentiality, licensing representations, data processing terms, indemnity caps, payroll correction SLA, and exit/data handoff. Vague “we handle compliance” language is not a term.
Sources
Related Decision Pages
Was this page helpful?
Tell us or send a correction.